196 related articles for article (PubMed ID: 6259649)
1. Kallikrein, kinins and blood pressure - effects of angiotensin-converting enzyme inhibition.
Johnston CI; Clappison B; McGrath BP; Matthews PG; Millar JA; Anderson WP
Prog Biochem Pharmacol; 1980; 17():123-33. PubMed ID: 6259649
[No Abstract] [Full Text] [Related]
2. Responses of the renin-angiotensin system and kallikrein-kinin system to sodium and converting enzyme inhibitor (SQ 14,225).
Matthews PG; Johnston CI
Adv Exp Med Biol; 1979; 120B():447-57. PubMed ID: 390990
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the acute effects of three structurally different converting enzyme inhibitors (captopril, SA-446 and MK-421) on blood pressure, the renin-angiotensin system and the kallikrein-kinin system.
Kondo K; Kida O; Kodama K; Higa T; Someya N; Morotomi Y; Tanaka K
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):337-42. PubMed ID: 2991635
[No Abstract] [Full Text] [Related]
4. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
Iimura O; Shimamoto K
Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
[TBL] [Abstract][Full Text] [Related]
5. Role of kallikrein-kinin system in the hypotensive mechanisms of converting enzyme inhibitors in essential hypertension.
Iimura O; Shimamoto K
J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S63-6. PubMed ID: 2474107
[TBL] [Abstract][Full Text] [Related]
6. [The kallikrein-kinin system and blood pressure regulation].
Yasujima M; Abe K
Nihon Rinsho; 1989 Sep; 47(9):1956-62. PubMed ID: 2593269
[No Abstract] [Full Text] [Related]
7. Kallikrein, kininogen and kinins in control of blood pressure.
Mills IH
Nephron; 1979; 23(2-3):61-71. PubMed ID: 375113
[TBL] [Abstract][Full Text] [Related]
8. Role of renin-angiotensin and kallikrein-kinin systems on the mechanism of the hypotensive effects of converting enzyme inhibitor, alacepril.
Tanaka S; Shimamoto K; Ando T; Nakahashi Y; Ura N; Hosoda S; Ishida H; Yamaji I; Yokoyama T; Masuda A
Clin Exp Hypertens A; 1987; 9(2-3):605-9. PubMed ID: 3038424
[TBL] [Abstract][Full Text] [Related]
9. Use of angiotensin antagonists in experimental and human renovascular hypertension.
Maxwell MH
Adv Nephrol Necker Hosp; 1979; 8():297-319. PubMed ID: 115245
[No Abstract] [Full Text] [Related]
10. The kallikrein-kinin system in blood pressure homeostasis.
Lee TC; Kushiro T; Gassia JP; Girolami JP; Lupu AN; Maxwell MH
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():255s-258s. PubMed ID: 94277
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic effects of captopril on the renin-angiotensin and kallikrein-kinin systems affecting blood pressure and natriuresis.
Kida O
Nihon Jinzo Gakkai Shi; 1985 Mar; 27(3):343-52. PubMed ID: 3894731
[No Abstract] [Full Text] [Related]
12. Influence of inhibition of angiotensin I converting enzyme with SQ-14225 on the arterial blood pressure of mongrel dogs.
Jandhyala BS; Washington GF; Lokhandwala MF
Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):257-65. PubMed ID: 216064
[TBL] [Abstract][Full Text] [Related]
13. The brain kallikrein-kinin system. A possible role in blood pressure regulation.
Scicli AG; Carretero OA
Hypertension; 1990 Apr; 15(4):413-4. PubMed ID: 2180819
[No Abstract] [Full Text] [Related]
14. [Factors related to natriuresis and anti-natriuresis. Kallikrein system].
Yamamoto K; Komori T; Okahara T; Abe Y
Nihon Rinsho; 1979; 37(2):304-9. PubMed ID: 374788
[No Abstract] [Full Text] [Related]
15. Does the renin-angiotensin system maintain blood pressure in both hypertensive and normotensive subjects? A comparison of propranolol, saralasin and captopril.
MacGregor GA; Markandu ND; Roulston JE
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():145s-148s. PubMed ID: 396068
[No Abstract] [Full Text] [Related]
16. Deterioration of renal function during angiotensin converting enzyme inhibition in hypertensive patients with a poorly functioning solitary kidney.
Rasmussen S; Ibsen H; Giese J
Scand J Urol Nephrol; 1985; 19(1):45-8. PubMed ID: 2992076
[TBL] [Abstract][Full Text] [Related]
17. Short-term treatment with captopril in hypertension due to acute glomerulonephritis.
Parra G; Rodríguez-Iturbe B; Colina-Chourio J; García R
Clin Nephrol; 1988 Feb; 29(2):58-62. PubMed ID: 3282729
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
Waeber B; Juillerat-Jeanneret L; Aubert JF; Schapira M; Nussberger J; Brunner HR
Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):175S-180S. PubMed ID: 2669913
[TBL] [Abstract][Full Text] [Related]
19. Prolongation of the saralasin responsive state of two-kidney, one clip Goldblatt hypertension in the rat by the orally administered converting enzyme inhibitor captopril (SQ14,225).
Weed WC; Vaughan ED; Peach MJ
Hypertension; 1979; 1(1):8-12. PubMed ID: 397195
[TBL] [Abstract][Full Text] [Related]
20. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
Nasjletti A; Colina-Chourio J; McGiff JC
Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
